Skip to Main Content
Aging | Mental Health & Behavioral Research, Phase IIA

A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy

What is the purpose of this trial?

The purpose of this study is to determine whether CVL-871 is safe and tolerable in patients with Dementia-Related Apathy and if CVL-871 shows changes in clinical measurements of apathy.

  • Trial with
    Cerevel Therapeutics, LLC
  • Ages
    50 years - 85 years
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Jeanine L. May

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    08/20/2024
  • Study HIC
    #2000030395